InfectoGnostics

InfectoGnostics

Breaking New Ground in Diagnostics of Infections

As a public-private partnership, the InfectoGnostics Research Campus Jena is breaking new ground in the diagnosis of infections. More than 30 partners from science, medicine and industry are working together to develop innovative solutions for the rapid and cost-effective on-site diagnosis of infectious diseases. As an Thuringian innovation cluster, InfectoGnostics is deeply rooted in Thuringia's innovation landscape and is also well connected with other clusters, commercial enterprises, research institutions, clinics and other stakeholders both nationally and internationally.

Read more our mission and the concept of our campus.

News

Find out more about current advancements in diagnostics and infection research in our most recent news or browse through our news archive.

InfectoGnostics and Reserach Campus Partners at MEDICA 2025 fair in Duesseldorf

InfectoGnostics showcased new results from the AVATAR consortium and our flagship projects at MEDICA 2025, together with strong Thuringian partners at the LEG joint booth in Diagnostics Hall 3.

Read more

InfectoGnostics joins BEAM Alliance

InfectoGnostics becomes part of the strong global AMR network

Read more

InfectoGnostics enters the third funding phase of the BMFTR's Research Campus Initiative

InfectoGnostics Enters Third Funding Phase of the BMFTR Research Campus Initiative

Nearly €8 million for seven new projects – this is the amount the InfectoGnostics Research Campus Jena has secured for the next four years. The public-private partnership for innovative solutions in infection diagnostics is thus entering the third and final phase of the federal funding initiative.

Read more

InfectoGnostics signs the Diversity Charter

The Diversity Charter promotes the recognition, appreciation, and inclusion of diversity in the world of work.

Read more

Events

Here you will find the current events in our network as well as an overview of previous events that have already taken place.

No news available.

Projects

  • NEXD

    Nanoreactor-bead extraction of cfDNA for hypothesis-free pathogen diagnostics

    Find out more about NEXD.

  • AutOoC

    Automated Organ-on-Chip platform for infection research

    AutOoC develops an automated Organ-on-Chip (OoC) platform to model bacterial lung infections and test antibiotic and nanoparticle-based therapies. Automated liquid handling enables standardized high-throughput generation of OoC models. By replicating human tissue structures, the system allows more predictive assessment of drug efficacy and accelerates the identification of effective treatments for persistent infections such as Staphylococcus aureus.

    Find out more about AutOoC.

  • CDI-NORO-POC

    Molecular point-of-care diagnostics for Clostridioides difficile and noroviruses

    This project develops a rapid molecular test for detecting Clostridioides difficile and noroviruses in nursing homes. The LAMP-based assay allows care staff to perform on-site testing, ensuring faster hygiene and containment measures. Using the portable eazyPlus device, stool samples are analyzed directly without lab processing. After laboratory validation, a field study will assess usability and accuracy for long-term implementation in healthcare settings.

    Find out more about CDI-NORO-POC.

  • PERFEKT

    Fully automated multi-parameter analyzer for decentralized infection diagnostics

    Find out more about PERFEKT.

  • QEID-POC

    Quantitative inflammation and infection diagnostics at the point of care

    Find out more about QEID-POC.

  • RamanProImmun

    Spectroscopic platform for blood infection diagnostics

    Find out more about RamanProImmun.

Partners

Under the maxim "diagnostics before therapy", we successfully realise projects as a public-private partnerships (PPP) with strong partners from industry and science. On the page "partners" you will find an overview of all our campus members.  Here you can first get to know a random selection of our partners: